3-(Boc-amino)-3-(bromomethyl)oxetane - CAS 1802048-91-4
Catalog: |
BB013650 |
Product Name: |
3-(Boc-amino)-3-(bromomethyl)oxetane |
CAS: |
1802048-91-4 |
Synonyms: |
N-[3-(bromomethyl)-3-oxetanyl]carbamic acid tert-butyl ester; tert-butyl N-[3-(bromomethyl)oxetan-3-yl]carbamate |
IUPAC Name: | tert-butyl N-[3-(bromomethyl)oxetan-3-yl]carbamate |
Description: | 3-(Boc-amino)-3-(bromomethyl)oxetane (CAS# 1802048-91-4 ) is a useful research chemical. |
Molecular Weight: | 266.13 |
Molecular Formula: | C9H16BrNO3 |
Canonical SMILES: | CC(C)(C)OC(=O)NC1(COC1)CBr |
InChI: | InChI=1S/C9H16BrNO3/c1-8(2,3)14-7(12)11-9(4-10)5-13-6-9/h4-6H2,1-3H3,(H,11,12) |
InChI Key: | SEUDVXPZTLKDKT-UHFFFAOYSA-N |
LogP: | 2.06590 |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]; H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]; H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation] |
Precautionary Statement: | P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
EP-3402782-B1 | 8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives | 20160113 |
AU-2015208244-A1 | Process for the preparation of N-[(3-aminooxetan-3-yl)methyl]-2-(1,1-dioxo-3,5-dihydro-1,4-benzothiazepin-4-yl)-6-methyl-quinazolin-4-amine | 20140124 |
AU-2015208244-B2 | Process for the preparation of N-[(3-aminooxetan-3-yl)methyl]-2-(1,1-dioxo-3,5-dihydro-1,4-benzothiazepin-4-yl)-6-methyl-quinazolin-4-amine | 20140124 |
EP-3097098-A1 | Process for the preparation of n-[(3-aminooxetan-3-yl)methyl]-2-(1,1-dioxo-3,5-dihydro-1,4-benzothiazepin-4-yl)-6-methyl-quinazolin-4-amine | 20140124 |
EP-3097098-B1 | Process for the preparation of n-[(3-aminooxetan-3-yl)methyl]-2-(1,1-dioxo-3,5-dihydro-1,4-benzothiazepin-4-yl)-6-methyl-quinazolin-4-amine | 20140124 |
Complexity: | 221 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 265.03136 |
Formal Charge: | 0 |
Heavy Atom Count: | 14 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 265.03136 |
Rotatable Bond Count: | 4 |
Topological Polar Surface Area: | 47.6 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.2 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Oxetane/Thietane
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS